May 31, 2016
The Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020 growing at a CAGR of 8.59% from 2015 to 2020. DelveInsight Report “Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF) -2020” provides an overview of the Antico...
Read More...
May 12, 2016
Global AF market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%. There are four NOACs which are indicated for the treatment of AF such as Xarelto, Eliquis, Pradaxa and Savaysa. DelveInsight Atrial Fibrillation-Market Insights & Drugs ...
Read More...
May 11, 2016
Venous Thromboembolism- Market Insights & Drugs Sales Forecast (VTE) -2020: New Report by DelveInsight suggests that the Global VTE market was $4.2 billion in 2015 and expected to grow to $4.75 billion by 2020 with a compound annual growth rate (CAGR) of 2.44%. DelveInsight Report “Venous Thromboembolism-Market ...
Read More...
Jun 13, 2015
DelveInsight is Hiring!!! Looking for Passionate Candidates Mail your updated Resume to careers@delveinsight.com JOB DESCRIPTION Profile Offered: Analyst (2-4 years Experienced) Education: M. Pharma/M.tech Biotech/MBA Biotech/B.Tech/ Roles and Responsibilities: Excellent editing, verbal and written ...
Read More...
Feb 27, 2015
Thanks to our great Clients, Partners, Colleagues, Family and Friends, we're celebrating the completion of our first year in business. Thanks for helping to make DelveInsight a success!!
Read More...
Sep 05, 2014
DelveInsight's Mechanism of Action Reports has become the Success Reason for the Leading Pharma Companies In this competitive world, everybody wants to get aware of what others are doing in their sectors and what strategic drivers are followed by the others for the successful future milestones. But the drug ...
Read More...
Aug 27, 2014
DelveInsight is helping worldwide Pharmaceutical companies with its Market Intelligence Reports. VISIT OUR WEBSITE Infectious Diseases and Vaccines The infectious disease (ID) vaccine pipeline is rich and robust. However, indications such as HIV, Tuberculosis and HCV have high demand for the development of a fi...
Read More...
Jul 03, 2014
We DELVEINSIGHT are Business Consultant and Knowledge Partner and have extensive experience across the value chain of pharmaceutical industry. Our company can provide valuable insight across all Pharmaceutical industries which include Drug Manufacturing to API Manufacturers&nb...
Read More...
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Newsletter/Whitepaper